Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $54.3B |
| FY2017, ended Dec 31, 2017 | $58.9B |
| FY2018, ended Dec 31, 2018 | $62.7B |
| FY2019, ended Dec 31, 2019 | $66.9B |
| FY2020, ended Dec 31, 2020 | $70.4B |
| FY2021, ended Dec 31, 2021 | $80.7B |
| FY2022, ended Dec 31, 2022 | $79.3B |
| FY2023, ended Dec 31, 2023 | $74.8B |
| FY2024, ended Dec 31, 2024 | $83.7B |
| FY2025, ended Dec 31, 2025 | $91.2B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $102B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $22.7B |
| FY2017, ended Dec 31, 2017 | $23.6B |
| FY2018, ended Dec 31, 2018 | $24.5B |
| FY2019, ended Dec 31, 2019 | $25.1B |
| FY2020, ended Dec 31, 2020 | $23.4B |
| FY2021, ended Dec 31, 2021 | $24.6B |
| FY2022, ended Dec 31, 2022 | $28.8B |
| FY2023, ended Dec 31, 2023 | $29.1B |
| FY2024, ended Dec 31, 2024 | $30.4B |
| FY2025, ended Dec 31, 2025 | $32.2B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $33.2B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.15B | −$1.04B |
| FY2017, ended Dec 31, 2017 | $3.06B | −$1.43B |
| FY2018, ended Dec 31, 2018 | $2.67B | −$2.20B |
| FY2019, ended Dec 31, 2019 | $3.75B | −$2.91B |
| FY2020, ended Dec 31, 2020 | $1.38B | −$1.05B |
| FY2021, ended Dec 31, 2021 | $3.91B | −$1.43B |
| FY2022, ended Dec 31, 2022 | $2.55B | −$5.44B |
| FY2023, ended Dec 31, 2023 | $2.84B | −$2.73B |
| FY2024, ended Dec 31, 2024 | $4.52B | $48.0M |
| FY2025, ended Dec 31, 2025 | $4.97B | −$1.69B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $5.14B | −$3.30B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $392M |
| FY2017, ended Dec 31, 2017 | $358M |
| FY2018, ended Dec 31, 2018 | $442M |
| FY2019, ended Dec 31, 2019 | $311M |
| FY2020, ended Dec 31, 2020 | $259M |
| FY2021, ended Dec 31, 2021 | $341M |
| FY2022, ended Dec 31, 2022 | $409M |
| FY2023, ended Dec 31, 2023 | $253M |
| FY2024, ended Dec 31, 2024 | $314M |
| FY2025, ended Dec 31, 2025 | $245M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $2.14B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $50.4B |
| FY2017, ended Dec 31, 2017 | $54.4B |
| FY2018, ended Dec 31, 2018 | $57.9B |
| FY2019, ended Dec 31, 2019 | $61.3B |
| FY2020, ended Dec 31, 2020 | $62.7B |
| FY2021, ended Dec 31, 2021 | $67.1B |
| FY2022, ended Dec 31, 2022 | $73.7B |
| FY2023, ended Dec 31, 2023 | $79.5B |
| FY2024, ended Dec 31, 2024 | $84.3B |
| FY2025, ended Dec 31, 2025 | $89.8B |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | $90.2B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 11.4% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 700M |
| FY2017, ended Dec 31, 2017 | 700M |
| FY2018, ended Dec 31, 2018 | 727M |
| FY2019, ended Dec 31, 2019 | 733M |
| FY2020, ended Dec 31, 2020 | 769M |
| FY2021, ended Dec 31, 2021 | 769M |
| FY2022, ended Dec 31, 2022 | 770M |
| FY2023, ended Dec 31, 2023 | 771M |
| FY2024, ended Dec 31, 2024 | 776M |
| FY2025, ended Dec 31, 2025 | 778M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | 780M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Paid to employees | Sold for cash |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $55.0M | $731M |
| FY2017, ended Dec 31, 2017 | $68.0M | — |
| FY2018, ended Dec 31, 2018 | $78.0M | $1.84B |
| FY2019, ended Dec 31, 2019 | $89.0M | $384M |
| FY2020, ended Dec 31, 2020 | $84.0M | $2.75B |
| FY2021, ended Dec 31, 2021 | $88.0M | $5.00M |
| FY2022, ended Dec 31, 2022 | $100M | $9.00M |
| FY2023, ended Dec 31, 2023 | $97.0M | $8.00M |
| FY2024, ended Dec 31, 2024 | $96.0M | $405M |
| FY2025, ended Dec 31, 2025 | $102M | $16.0M |
| Trailing 12 months to Mar 31, 2026 (through Q1 FY2026) | — | — |
Valuation
At current price- Market Cap
- $97.3B
- P/E
- 18.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 2.9×
- Price / Book
- 1.8×
- EV / EBITDA
- 11.0×
Growth
Trailing 12 months- Revenue (TTM)
- $33.2B
- Revenue Growth YoY
- 7.2%
- Revenue CAGR 3Y
- 3.9%
- Revenue CAGR 5Y
- 6.6%
- EPS Growth YoY
- 8.1%
- Net Income Growth YoY
- 7.8%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 27.2%
- Net Margin
- 15.5%
- FCF Margin
- −9.9%
- Return on Equity
- 9.8%
Earnings
Trailing 12 months- Net Income
- $5.14B
- EPS (diluted)
- $6.52
- EBITDA
- $16.9B
- Operating Income
- $9.01B
Balance Sheet
As of Mar 31, 2026- Cash and cash equivalents
- $2.14B
- Total Debt
- $90.2B
- Net Debt
- $88.1B
- Total Assets
- $198B
- Total Liabilities
- $142B
- Shareholders' Equity
- $54.5B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $11.7B
- Capital Expenditure
- $15.0B
- Free Cash Flow
- −$3.30B
Dividends and risk
Last 12 months- Dividend Yield
- 3.4%
- Dividend / Share
- $4.28
- Beta (5Y)
- 0.36
Every ratio is calculated from the company’s reported figures.